{
    "root": "0aca9c58-9720-420b-a0fa-3ef6c841f35c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Heparin Sodium",
    "value": "20250415",
    "ingredients": [
        {
            "name": "HEPARIN SODIUM",
            "code": "ZZ45AB24CA"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "heparin sodium injection indicated : •prophylaxis treatment venous thrombosis pulmonary embolism ; •prevention postoperative deep venous thrombosis pulmonary embolism patients undergoing major abdominothoracic surgery , reasons , risk developing thromboembolic disease ; •atrial fibrillation embolization ; •treatment acute chronic consumptive coagulopathies ( disseminated intravascular coagulation ) ; •prevention clotting arterial cardiac surgery ; •prophylaxis treatment peripheral arterial embolism . •anticoagulant blood transfusions , extracorporeal circulation , dialysis procedures .",
    "contraindications": "recommended adult dosages : • therapeutic anticoagulant effect full-dose heparin † ( 2.4 ) deep subcutaneous ( intrafat ) injection different site injection initial dose 5,000 units intravenous injection , followed 10,000 20,000 units concentrated solution , subcutaneously every 8 hours every 12 hours 8,000 10,000 units concentrated solution 15,000 20,000 units concentrated solution intermittent intravenous injection initial dose 10,000 units , either undiluted 50 100 ml 0.9 % sodium chloride injection , usp every 4 6 hours 5,000 10,000 units , either undiluted 50 100 ml 0.9 % sodium chloride injection , usp intravenous infusion initial dose 5,000 units intravenous injection continuous 20,000 40,000 units/24 hours 1000 ml 0.9 % sodium chloride injection , usp ( compatible solution ) infusion † based 150 lb ( 68 kg ) patient . adjust dose based laboratory monitoring .",
    "warningsAndPrecautions": "heparin sodium injection , usp preserved benzyl alcohol clear solution available following strengths package sizes single-dose vials : description ndc 1,000 usp units per ml ( 1 ml-fill ) 25 vials : 1,000 usp units per ml , single-dose * 67457-372-99 5,000 usp units per ml ( 1 ml-fill ) 25 vials : 5,000 usp units per ml , single-dose * 67457-374-99 10,000 usp units per ml ( 1 ml-fill ) 25 vials : 10,000 usp units per ml , single-dose * 67457-602-99 * discard unused portion heparin sodium injection , usp preserved benzyl alcohol clear solutionis available following strengths package sizes multiple-dose vials : description ndc 1,000 usp units per ml ( 10 ml-fill ) 25 vials : 10,000 usp units per 10 ml , multiple-dose 67457-385-99 1,000 usp units per ml ( 30 ml-fill ) 25 vials : 30,000 usp units per 30 ml , multiple-dose 67457-384-99 5,000 usp units per ml ( 10 ml-fill ) 25 vials : 50,000 usp units per 10 ml , multiple-dose 67457-383-99 10,000 usp units per ml ( 4 ml-fill ) 25 vials : 40,000 usp units per 4 ml , multiple-dose 67457-603-99 store 20° 25°c ( 68° 77°f ) . [ usp controlled room temperature . ]",
    "adverseReactions": "heparin sodium injection contraindicated patients following conditions : •history heparin-induced thrombocytopenia heparin-induced thrombocytopenia thrombosis [ ( 5.3 ) ] ; •known hypersensitivity heparin pork products ( e.g . , anaphylactoid ) [ ( 6.1 ) ] ; •in suitable blood coagulation tests , e.g . , whole blood clotting time , partial thromboplastin time , etc . , performed appropriate intervals ( contraindication refers full-dose heparin ; usually need monitor coagulation parameters patients receiving low-dose heparin ) ; •an uncontrolled active bleeding state [ ( 5.2 ) ] , except due disseminated intravascular coagulation .",
    "indications_original": "Heparin sodium injection is indicated for: \n                  \n                     \n                        •Prophylaxis and treatment of venous thrombosis and pulmonary embolism; \n                     \n                        •Prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; \n                     \n                        •Atrial fibrillation with embolization; \n                     \n                        •Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); \n                     \n                        •Prevention of clotting in arterial and cardiac surgery; \n                     \n                        •Prophylaxis and treatment of peripheral arterial embolism. \n                     \n                        •Anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures.",
    "contraindications_original": "Recommended Adult Dosages: • Therapeutic Anticoagulant Effect with Full-Dose Heparin † ( 2.4 ) Deep Subcutaneous (Intrafat) Injection Use a different site for each injection Initial Dose 5,000 units by intravenous injection, followed by 10,000 to 20,000 units of a concentrated solution, subcutaneously Every 8 hours or Every 12 hours 8,000 to 10,000 units of a concentrated solution 15,000 to 20,000 units of a concentrated solution Intermittent Intravenous Injection Initial dose 10,000 units, either undiluted or in 50 to 100 mL of 0.9% Sodium Chloride Injection, USP Every 4 to 6 hours 5,000 to 10,000 units, either undiluted or in 50 to 100 mL of 0.9% Sodium Chloride Injection, USP Intravenous Infusion Initial dose 5,000 units by intravenous injection Continuous 20,000 to 40,000 units/24 hours in 1000 mL of 0.9% Sodium Chloride Injection, USP (or in any compatible solution) for infusion † Based on 150 lb (68 kg) patient. Adjust dose based on laboratory monitoring.",
    "warningsAndPrecautions_original": "Heparin Sodium Injection, USP preserved with benzyl alcohol clear solution is available in the following strengths and package sizes in single-dose vials:\n                  \n                     \n                     \n                     \n                        \n                           \n                              \n                                 DESCRIPTION \n                              \n                           \n                           \n                              \n                                 NDC \n                              \n                           \n                        \n                        \n                           \n                              \n                                 1,000 USP units per mL (1 mL-fill)\n                              \n                           \n                        \n                        \n                           \n                                  25 vials: 1,000 USP units per mL, single-dose*\n                           \n                           \n                              \n                                 67457-372-99\n                              \n                           \n                        \n                        \n                           \n                              \n                                 5,000 USP units per mL (1 mL-fill)\n                              \n                           \n                        \n                        \n                           \n                                  25 vials: 5,000 USP units per mL, single-dose* \n                           \n                           \n                              \n                                 67457-374-99 \n                              \n                           \n                        \n                        \n                           \n                              \n                                 10,000 USP units per mL (1 mL-fill)\n                              \n                           \n                        \n                        \n                           \n                                  25 vials: 10,000 USP units per mL, single-dose*\n                           \n                           \n                              \n                                 67457-602-99 \n                              \n                           \n                        \n                     \n                  \n                  \n                     *Discard unused portion\n                  Heparin Sodium Injection, USP preserved with benzyl alcohol clear solutionis available in the following strengths and package sizes in multiple-dose vials: \n                  \n                     \n                     \n                     \n                        \n                           \n                              \n                                 DESCRIPTION \n                              \n                           \n                           \n                              \n                                 NDC \n                              \n                           \n                        \n                        \n                           \n                              \n                                 1,000 USP units per mL (10 mL-fill)\n                              \n                           \n                        \n                        \n                           \n                                  25 vials: 10,000 USP units per 10 mL, multiple-dose \n                           \n                           \n                              \n                                 67457-385-99\n                              \n                           \n                        \n                        \n                           \n                              \n                                 1,000 USP units per mL (30 mL-fill)\n                              \n                           \n                        \n                        \n                           \n                                  25 vials: 30,000 USP units per 30 mL, multiple-dose \n                           \n                           \n                              \n                                 67457-384-99 \n                              \n                           \n                        \n                        \n                           \n                              \n                                 5,000 USP units per mL (10 mL-fill)\n                              \n                           \n                        \n                        \n                           \n                                  25 vials: 50,000 USP units per 10 mL, multiple-dose \n                           \n                           \n                              \n                                 67457-383-99 \n                              \n                           \n                        \n                        \n                           \n                              \n                                 10,000 USP units per mL (4 mL-fill)\n                              \n                           \n                        \n                        \n                           \n                                  25 vials: 40,000 USP units per 4 mL, multiple-dose \n                           \n                           \n                              \n                                 67457-603-99 \n                              \n                           \n                        \n                     \n                  \n                  \n                     Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]",
    "adverseReactions_original": "The use of heparin sodium injection is contraindicated in patients with the following conditions: \n                  \n                     \n                        •History of heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis [see Warnings and Precautions (5.3)]; \n                     \n                        •Known hypersensitivity to heparin or pork products (e.g., anaphylactoid reactions) [see Adverse Reactions (6.1)]; \n                     \n                     \n                        •In whom suitable blood coagulation tests, e.g., the whole blood clotting time, partial thromboplastin time, etc., cannot be performed at appropriate intervals (this contraindication refers to full-dose heparin; there is usually no need to monitor coagulation parameters in patients receiving low-dose heparin); \n                     \n                        •An uncontrolled active bleeding state [see Warnings and Precautions (5.2)\n                        ], except when this is due to disseminated intravascular coagulation."
}